system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht
recognition Drug license Manufacturing service (OEM) Contracts with a customer ▪ บรษัิทยาท าสญัญาขายทะเบยีนต ารับยาทีไ่ดข้ ึน้ ทะเบยีนยากบั อย. แลว้ ใหล้กูคา้ ▪ ลกูคา้ยังไมไ่ดรั้บโอน ทะเบยีนต ารับยาตาม กฎหมาย
details on the evidence list. Besides, the Law requires only the procedure for taking evidence by the plaintiff and the defendant, i.e., the sequence of examination, cross-examination and re-examination. In
and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31
is a high growth segment, especially in the non-PET-related, predominantly olefins-based, sustainable packaging materials serving key needs in the FMCG and pharmaceutical industries. This downstream
LIMITED JMT NETWORK SERVICES PUBLIC COMPANY LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED K&K SUPERWHOLESALE HATYAI 2009 PUBLIC COMPANY
PUBLIC COMPANY LIMITED SERIPREMIER COMPANY LIMITED SERMSANG POWER CORPORATION PUBLIC COMP... SERMSUK PUBLIC COMPANY LIMITED SEVEN STARS PHARMACEUTICAL COMPANY LIM... SG CAPITAL PUBLIC COMPANY LIMITED SGF
1 Synergistic effects of CSR practices on firm value: Evidence from Asia Pacific emerging markets Boonlert Jitmaneeroj School of Business, University of the Thai Chamber of Commerce Abstract Corporate social responsibility (CSR) has several attributes that are inherently unobservable or measured with errors. This study proposes an alternative methodology to account for measurement errors in CSR proxies. In this spirit, this study considers CSR to be a latent variable measured by environmental (E...
[day/month/year] 2 Sequence of debt repayment in the case of the bankruptcy or the dissolution of the issuer. Characteristics and Conditions on Returns (principal/interest) Important Warnings Special